Loading...
Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives
BACKGROUND: Median survival of metastatic malignant melanoma is 6.0 to 7.5 months, with a 5-year survival of ~6.0%. Although long-term complete remissions are rare, few reports describe cases after chemotherapy. Fifty-three patients with metastatic melanoma were treated with Cystemustine, a chloroet...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2005
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1310625/ https://ncbi.nlm.nih.gov/pubmed/16287507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-5-147 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|